Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
53,537,619
-
Share change
-
+237,217
-
Total reported value
-
$1,092,710,410
-
Put/Call ratio
-
80%
-
Price per share
-
$20.41
-
Number of holders
-
105
-
Value change
-
+$7,578,886
-
Number of buys
-
40
-
Number of sells
-
49
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q1 2021
As of 31 Mar 2021,
Theravance Biopharma, Inc. - Common Stock (TBPH) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,537,619 shares.
The largest 10 holders included
FMR LLC, BAUPOST GROUP LLC/MA, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Chescapmanager LLC, GEODE CAPITAL MANAGEMENT, LLC, and Laurion Capital Management LP.
This page lists
105
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.